Position in BCRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$846,099
+$152,867 QoQ
Shares Held
88,876
0.0% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PANAGORA ASSET MANAGEMENT INC holds $90,304,727 across 13 Drug Manufacturers - Specialty & Generic names. BCRX ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
932,942 | $32,988,829 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
34,953 | $20,726,429 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
151,449 | $19,951,891 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
260,686 | $6,238,215 | |
| 5 | HROW |
Harrow, Inc.
|
86,097 | $3,035,780 | |
| 6 | ADCT |
ADC Therapeutics SA
|
691,275 | $2,592,281 | |
| 7 | ZTS |
Zoetis Inc.
|
15,203 | $1,797,146 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
88,876 | $846,099 |
All Filings in BCRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $846,099 | 88,876 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $693,232 | 88,876 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $940,142 | 123,866 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,530,544 | 394,034 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,971,775 | 529,570 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,286,509 | 835,972 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,139,819 | 676,292 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,018,965 | 650,318 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $3,213,399 | 632,559 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $4,007,711 | 669,067 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $5,150,558 | 727,480 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $4,825,983 | 685,509 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,770,304 | 691,883 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,985,499 | 695,601 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,332,520 | 502,581 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,080,727 | 385,702 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,374,050 | 392,008 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,536,318 | 327,532 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,210,344 | 223,406 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $46,007 | 2,910 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $4,932 | 485 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,495 | 335 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||